Cardiomyopathy-Associated Hospital Admissions Among Methamphetamine Users: Geographical and Social Disparities

Background: Methamphetamine is an emerging drug threat. The disparity in cardiomyopathy-associated hospital admissions among methamphetamine users (CAHMA) over the decade remains unknown.

Objectives: The purpose of this study was to determine the trends and prevalence of CAHMA by age, sex, race, and geographical region.

Methods: We used data from 2008 to 2020 from the National Inpatient Sample database. We identified 12,845,919 cardiomyopathy-associated hospital admissions; among them, 222,727 were diagnosed as methamphetamine users. A generalized linear model with binomial link function was used to compute the prevalence ratio and 95% CI. Those who used other substances along with methamphetamine were excluded from the analysis.

Results: CAHMA increased by 231% ( trend <0.001) from 2008 to 2020. CAHMA increased 345% for men ( trend <0.001) and 122% for women ( trend <0.001), 271% for non-Hispanic White ( trend <0.001), 254% for non-Hispanic Black (p trend <0.001), 565% for Hispanic ( trend <0.001), and 645% for non-Hispanic Asian ( trend <0.001) population. CAHMA also increased significantly in the West region (530%) ( trend <0.001) and South region (200%) ( trend <0.001) of the United States. Men, Hispanic population, age groups 26 to 40 and 41 to 64 years, and Western regions showed a significantly higher uptrend than their counterparts ( trend <0.001).

Conclusions: CAHMA have increased significantly in the United States. Men, Hispanics, non-Hispanic Asian, age groups 41 to 64. and western regions showed a higher proportional increase highlighting gender-based, racial/ethnic, and regional disparities over the study period.